Scholarlink

Background <p>Sentinel lymph node (SLN) biopsy is a diagnostic staging procedure in early-stage oral squamous cell carcinoma (OSCC). The conventional method using tracers labeled with <sup>99m</sup>Tc is limited by the’shine-through’ phenomenon, a situation where intense tracer uptake at the injection site obscures nearby lymph nodes, making them difficult to detect. This effect is particularly problematic in floor of mouth tumors, where the sentinel nodes are often located close to the primary tumor. Tracing lymphatic drainage of the tumor with superparamagnetic iron oxide nanoparticles (SPIO) in combination with magnetic resonance imaging (MRI) provides superior anatomical detail over the use of radioactive tracers, which may improve the detection of SLNs. This multicenter clinical trial aims to evaluate the diagnostic accuracy of a complete magnetic SLN biopsy procedure in early-stage OSCC.</p> Methods <p>This prospective multicenter trial will enroll 82 patients with early-stage OSCC undergoing transoral resection and SLN biopsy. The complete magnetic SLN biopsy procedure includes peritumoral SPIO injection, preoperative SPIO-enhanced magnetic resonance (MR) lymphography, and intraoperative SLN detection by a magnetometer. Results will be compared to the conventional SLN biopsy using a [<sup>99m</sup>Tc]Tc-nanocolloid tracer and indocyanine green. Sensitivity, negative predictive value (NPV), interobserver reliability, and patient perspectives will be assessed.</p> Discussion <p>A complete magnetic SLN biopsy may improve staging accuracy in OSCC by addressing radiotracer limitations and potentially reducing false-negative rates. This technique could potentially be expanded to other cancers, offering a radiation-free alternative to conventional SLN biopsy methods.</p> Trial registration <p>This trial is approved by the Medical Research Ethical Committee NedMec (number: 2023/157) and registered in the Netherlands Trial Register (registration number: NL81165.041.22).</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Magnetic sentinel lymph node detection using superparamagnetic iron oxide in early-stage oral squamous cell carcinoma: design and rationale of the multicenter magnetics trial – study protocol

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年10月9日

查看全文
  • Dominique N. V. Donders,
  • Gijs T. N. Heldens,
  • Roosmarijn S. Tellman,
  • Robert P. Takes,
  • Alexander J. M. van Bemmel,
  • Sebastiaan A. H. J. de Visscher,
  • Hossein Ghaeminia,
  • Lejla Alic,
  • Marielle E. P. Philippens,
  • Tom W. J. Scheenen,
  • Bart de Keizer,
  • Remco de Bree

摘要

Background

Sentinel lymph node (SLN) biopsy is a diagnostic staging procedure in early-stage oral squamous cell carcinoma (OSCC). The conventional method using tracers labeled with 99mTc is limited by the’shine-through’ phenomenon, a situation where intense tracer uptake at the injection site obscures nearby lymph nodes, making them difficult to detect. This effect is particularly problematic in floor of mouth tumors, where the sentinel nodes are often located close to the primary tumor. Tracing lymphatic drainage of the tumor with superparamagnetic iron oxide nanoparticles (SPIO) in combination with magnetic resonance imaging (MRI) provides superior anatomical detail over the use of radioactive tracers, which may improve the detection of SLNs. This multicenter clinical trial aims to evaluate the diagnostic accuracy of a complete magnetic SLN biopsy procedure in early-stage OSCC.

Methods

This prospective multicenter trial will enroll 82 patients with early-stage OSCC undergoing transoral resection and SLN biopsy. The complete magnetic SLN biopsy procedure includes peritumoral SPIO injection, preoperative SPIO-enhanced magnetic resonance (MR) lymphography, and intraoperative SLN detection by a magnetometer. Results will be compared to the conventional SLN biopsy using a [99mTc]Tc-nanocolloid tracer and indocyanine green. Sensitivity, negative predictive value (NPV), interobserver reliability, and patient perspectives will be assessed.

Discussion

A complete magnetic SLN biopsy may improve staging accuracy in OSCC by addressing radiotracer limitations and potentially reducing false-negative rates. This technique could potentially be expanded to other cancers, offering a radiation-free alternative to conventional SLN biopsy methods.

Trial registration

This trial is approved by the Medical Research Ethical Committee NedMec (number: 2023/157) and registered in the Netherlands Trial Register (registration number: NL81165.041.22).